Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada

Diagnostic Microbiology and Infectious Disease

Volumn 77, Issue 4, 2013, Pages 350-353

  Patel, Samir N ^a,b   Memari, Nader ^a   Shahinas, Dea ^a   Toye, Baldwin ^c   Jamieson, Frances B ^a,b   Farrell, David J ^a,b  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cfr gene; Enterococcus; Linezolid; Susceptibility testing; VRE

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; LINEZOLID; RNA 23S; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANADA; CFR GENE; CLINICAL ARTICLE; ENTEROCOCCUS FAECIUM; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VANA GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CFR GENE; ENTEROCOCCUS; LINEZOLID; SUSCEPTIBILITY TESTING; VRE;

ACETAMIDES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; FEMALE; GENES, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; MUTATION; ONTARIO; OXAZOLIDINONES;

EID: 84887615794     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.08.012     Document Type: Article

References (35)

1. Aanensen D.M., Spratt B.G. The multilocus sequence typing network: mlst.net. Nucleic Acids Res 2005, 33:W728-W733.
2. Aoki H., Ke L., Poppe S.M., Poel T.J., Weaver E.A., Gadwood R.C., et al. Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes. Antimicrob Agents Chemother 2002, 46:1080-1085.
3. Argudin M.A., Tenhagen B.A., Fetsch A., Sachsenroder J., Kasbohrer A., Schroeter A., et al. Virulence and resistance determinants of German Staphylococcus aureus ST398 isolates from nonhuman sources. Appl Environ Microbiol 2011, 77:3052-3060.
4. Arias C.A., Murray B.E. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012, 10:266-278.
5. Arias C.A., Murray B.E. Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther 2008, 6:637-655.
6. Biedenbach D.J., Farrell D.J., Mendes R.E., Ross J.E., Jones R.N. Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox(R) Annual Appraisal of Potency and Spectrum program. Diagn Microbiol Infect Dis 2010, 68:459-467.
7. Bonilla H., Huband M.D., Seidel J., Schmidt H., Lescoe M., McCurdy S.P., et al. Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. Clin Infect Dis 2010, 51:796-800.
8. Bourdon N., Fines-Guyon M., Thiolet J.M., Maugat S., Coignard B., Leclercq R., Cattoir V. Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08. J Antimicrob Chemother 2011, 66:713-721.
9. Boyd D.A., Cabral T., Van Caeseele P., Wylie J., Mulvey M.R. Molecular characterization of the vanE gene cluster in vancomycin-resistant Enterococcus faecalis N00-410 isolated in Canada. Antimicrob Agents Chemother 2002, 46:1977-1979.
10. Boyd D.A., Miller M.A., Mulvey M.R. Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) gene. Antimicrob Agents Chemother 2006, 50:1067-1070.
11. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - ninth edition, M07-A9 2012, CLSI, Wayne, PA.
12. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 23rd informational supplement (M100-S23) 2013, CLSI, Wayne, PA.
13. Diaz L., Kiratisin P., Mendes R.E., Panesso D., Singh K.V., Arias C.A. Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis. Antimicrob Agents Chemother 2012, 56:3917-3922.
14. Elsayed S., Hamilton N., Boyd D., Mulvey M. Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. J Clin Microbiol 2001, 39:2367-2368.
15. Flamm R.K., Farrell D.J., Mendes R.E., Ross J.E., Sader H.S., Jones R.N. LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers). Diagn Microbiol Infect Dis 2012, 74:54-61.
16. Flamm R.K., Mendes R.E., Ross J.E., Sader H.S., Jones R.N. An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011. Diagn Microbiol Infect Dis 2013.
17. Flamm R.K., Mendes R.E., Ross J.E., Sader H.S., Jones R.N. Linezolid surveillance results for the United States: LEADER surveillance program 2011. Antimicrob Agents Chemother 2013, 57:1077-1081.
18. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
19. Kaminska K.H., Purta E., Hansen L.H., Bujnicki J.M., Vester B., Long K.S. Insights into the structure, function and evolution of the radical-SAM 23S rRNA methyltransferase Cfr that confers antibiotic resistance in bacteria. Nucleic Acids Res 2010, 38:1652-1663.
20. Kehrenberg C., Aarestrup F.M., Schwarz S. IS21-558 insertion sequences are involved in the mobility of the multiresistance gene cfr. Antimicrob Agents Chemother 2007, 51:483-487.
21. Kehrenberg C., Schwarz S. Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother 2006, 50:1156-1163.
22. Long K.S., Poehlsgaard J., Kehrenberg C., Schwarz S., Vester B. The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 2006, 50:2500-2505.
23. Mendes R.E., Deshpande L.M., Castanheira M., DiPersio J., Saubolle M.A., Jones R.N. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 2008, 52:2244-2246.
24. Mendes R.E., Deshpande L., Rodriguez-Noriega E., Ross J.E., Jones R.N., Morfin-Otero R. First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization. J Clin Microbiol 2010, 48:3041-3043.
25. Mendes R.E., Deshpande L.M., Farrell D.J., Spanu T., Fadda G., Jones R.N. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J Antimicrob Chemother 2010, 65:2329-2335.
26. Mendes R.E., Deshpande L.M., Costello A.J., Farrell D.J. Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals. Antimicrob Agents Chemother 2012, 56:4656-4661.
27. Morales G., Picazo J.J., Baos E., Candel F.J., Arribi A., Pelaez B., et al. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis 2010, 50:821-825.
28. Nihonyanagi S., Adachi Y., Onuki T., Nakazaki N., Hirata Y., Fujiki K., et al. Emergence of linezolid-resistant Enterococcus faecalis strains from two inpatients in a pediatric ward. Kansenshogaku Zasshi 2012, 86:555-562.
29. Ntokou E., Stathopoulos C., Kristo I., Dimitroulia E., Labrou M., Vasdeki A., et al. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother 2012, 67:1819-1823.
30. Prystowsky J., Siddiqui F., Chosay J., Shinabarger D.L., Millichap J., Peterson L.R., Noskin G.A. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 2001, 45:2154-2156.
31. Quiles-Melero I., Gomez-Gil R., Romero-Gomez M.P., Sanchez-Diaz A.M., de Pablos M., Garcia-Rodriguez J., et al. Mechanisms of linezolid resistance among staphylococci in a tertiary hospital. J Clin Microbiol 2013, 51:998-1001.
32. Sanchez Garcia M., De la Torre M.A., Morales G., Pelaez B., Tolon M.J., Domingo S., et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010, 303:2260-2264.
33. Schwarz S., Werckenthin C., Kehrenberg C. Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri. Antimicrob Agents Chemother 2000, 44:2530-2533.
34. Tsiodras S., Gold H.S., Sakoulas G., Eliopoulos G.M., Wennersten C., Venkataraman L., et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001, 358:207-208.
35. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (2011) 10th edition of Manual of Clinical Microbiology.